The Interplay Between Cardiovascular Disease and Lung Cancer
Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, hea...
Saved in:
Published in | Curēus (Palo Alto, CA) Vol. 16; no. 6; p. e62953 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Cureus Inc
23.06.2024
Cureus |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer. |
---|---|
AbstractList | Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer.Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer. Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer. Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient management and treatment outcomes. This review explores the complex relationship between various forms of CVD - such as coronary artery disease, heart failure (HF), arrhythmias, and valvular heart disease - and lung cancer. Shared risk factors, including smoking, aging, and chronic inflammation, contribute to the co-occurrence of these conditions. Additionally, treatments for lung cancer, particularly chemotherapy and radiation therapy, can exacerbate CVD, necessitating a multidisciplinary approach to patient care. We delve into specific CVD-related impacts on lung cancer prognosis and vice versa, examining mechanisms, clinical outcomes, and management strategies. Our findings highlight the need for integrated care involving oncologists, cardiologists, and other healthcare providers to optimize treatment plans and improve patient outcomes. Emphasizing comprehensive cardiovascular risk management in lung cancer patients, we advocate for further research to deepen our understanding and develop novel therapeutic approaches, ultimately enhancing the quality of life and survival rates in patients suffering from both CVD and lung cancer. |
Author | Gulati, Amit Diaz Saravia, Sara Gupta, Soumya Nagourney, Alexander Choi, James Tsyvkin, Elina Silverman, Alexander Katic, Luka Torelli, Vincent Glavan, Martina Khurana, Sakshi |
AuthorAffiliation | 4 Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA 5 Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA 1 Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA 2 Neuroscience, Yale University, New Haven, USA 3 Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA |
AuthorAffiliation_xml | – name: 3 Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA – name: 1 Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – name: 5 Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA – name: 2 Neuroscience, Yale University, New Haven, USA – name: 4 Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA |
Author_xml | – sequence: 1 givenname: Luka surname: Katic fullname: Katic, Luka organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 2 givenname: James surname: Choi fullname: Choi, James organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 3 givenname: Sara surname: Diaz Saravia fullname: Diaz Saravia, Sara organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 4 givenname: Alexander surname: Silverman fullname: Silverman, Alexander organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 5 givenname: Alexander surname: Nagourney fullname: Nagourney, Alexander organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 6 givenname: Vincent surname: Torelli fullname: Torelli, Vincent organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 7 givenname: Soumya surname: Gupta fullname: Gupta, Soumya organization: Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 8 givenname: Martina surname: Glavan fullname: Glavan, Martina organization: Neuroscience, Yale University, New Haven, USA – sequence: 9 givenname: Amit surname: Gulati fullname: Gulati, Amit organization: Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA – sequence: 10 givenname: Sakshi surname: Khurana fullname: Khurana, Sakshi organization: Radiology, New York Presbyterian-Columbia University Irving Medical Center, New York, USA – sequence: 11 givenname: Elina surname: Tsyvkin fullname: Tsyvkin, Elina organization: Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39044884$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1Lw0AQxRdRrFZvniXgxYPV2c9sQBCtX4WCFz0vm81UU9JN3U0q_e9NbRX1NMO8H495vH2y7WuPhBxROE9TmV24NmAbzxXLJN8ie4wqPdBUi-1fe48cxjgFAAopgxR2SY9nIITWYo9cPr9hMvINhnlll8kNNh-IPhnaUJT1wkbXVjYkt2VEGzGxvkjGrX_tdO8wHJCdia0iHm5mn7zc3z0PHwfjp4fR8Ho8cBygGfCMie5DCsoCyqKA7swFQpaiFkLJHKly1lGeM3QTkDJnE62YxAxVkVPN--Rq7Ttv8xkWDn0TbGXmoZzZsDS1Lc1fxZdv5rVeGEqZkkyuHE43DqF-bzE2ZlZGh1VlPdZtNBy0AJZlmnboyT90WrfBd_lWlEpTCkx21NmacqGOMeDk5xsKZlWNWVdjvqrp8OPfCX7g7yL4J23ei3s |
Cites_doi | 10.1002/ejhf.1058 10.1097/CM9.0000000000002529 10.1093/annonc/mdl287 10.1080/14779072.2019.1691528 10.1186/s40425-017-0245-2 10.1155/2015/971453 10.1038/nrcardio.2014.211 10.1056/NEJM199707033370107 10.1016/j.blre.2019.03.005 10.1002/cam4.2183 10.3892/mco.2014.289 10.1007/s00330-014-3191-0 10.1093/icvts/ivab140 10.1016/S1470-2045(14)71180-5 10.36660/abc.20190201 10.1038/s41598-019-55060-7 10.1159/000196195 10.2214/AJR.10.5577 10.1016/s0735-1097(01)01788-0 10.1073/pnas.2200476119 10.1016/j.jacc.2020.03.001 10.36660/abc.20200478 10.3390/cancers15245723 10.1093/europace/euy268 10.1161/CIRCHEARTFAILURE.109.930701 10.1016/j.jaccao.2020.02.003 10.1002/jcp.28350 10.1016/j.cmpb.2015.12.024 10.1093/annonc/mdw640 10.15420/aer.2018:15:2 10.1097/00004872-200204000-00003 10.1164/rccm.201407-1395OC 10.1201/9781420006438 10.1056/NEJMsa1407211 10.1093/aje/kwu124 10.4065/mcp.2009.0706 10.1016/j.pcl.2005.10.004 10.1002/ejhf.1539 10.1161/CIRCULATIONAHA.120.047293 10.1016/s1010-7940(96)01097-4 10.1007/s00380-007-0979-8 10.1093/annonc/mdq042 10.1111/1759-7714.14174 10.3322/caac.21660 10.1016/0002-8703(83)90003-0 10.3390/jcm9051268 10.3978/j.issn.2072-1439.2011.02.03 10.1200/JCO.2007.10.9777 10.1136/heartjnl-2015-308765 10.1161/01.cir.0000025242.79963.4c 10.1177/10781552211004698 10.1161/CIRCEP.117.005443 10.1016/j.jacc.2019.07.079 10.11909/j.issn.1671-5411.2022.08.003 10.1371/journal.pone.0215246 10.1136/bmj.1.6107.210 10.1016/j.ccm.2019.10.001 10.1093/ehjqcco/qcac016 10.1097/00004872-200204000-00017 10.3389/fimmu.2022.871542 10.1186/1471-2407-6-129 10.1097/CRD.0b013e3182431c23 10.1093/icvts/ivu218 10.1177/1534735419869491 10.1016/j.cell.2020.04.034 10.1016/bs.vh.2017.05.007 10.1097/SLA.0000000000001626 10.1161/CIR.0000000000000986 10.1007/s10554-015-0664-4 10.21037/tlcr-22-493 10.2147/ITT.S125070 10.7150/ijbs.35460 10.1097/01.hjh.0000746336.69196.25 10.3389/fonc.2022.934369 10.1007/s00595-016-1355-z 10.1093/cvr/cvaa241 10.1038/nrendo.2012.99 10.1016/0735-1097(95)80037-h 10.1097/01.hjh.0000745076.39504.af 10.21037/jtd.2018.03.104 10.3390/biom13101490 |
ContentType | Journal Article |
Copyright | Copyright © 2024, Katic et al. Copyright © 2024, Katic et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2024, Katic et al. 2024 Katic et al. |
Copyright_xml | – notice: Copyright © 2024, Katic et al. – notice: Copyright © 2024, Katic et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2024, Katic et al. 2024 Katic et al. |
DBID | NPM AAYXX CITATION 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH K9. M0S PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.7759/cureus.62953 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) Coronavirus Research Database ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X7 name: Health & Medical Complete (ProQuest Database) url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2168-8184 |
ExternalDocumentID | 10_7759_cureus_62953 39044884 |
Genre | Journal Article Review |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: P30 CA008748 |
GroupedDBID | 3V. 53G 5VS 7X7 8FI 8FJ ABUWG ADBBV ADRAZ AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR BPHCQ BVXVI CCPQU FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M48 NPM OK1 PGMZT PIMPY PQQKQ PROAC RPM UKHRP AAYXX CITATION 7XB 8FK AZQEC COVID DWQXO K9. PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c300t-3924629106a0e5dd0c3034e097e84465be16cac13b2ecf055b2f8625e9e6db183 |
IEDL.DBID | RPM |
ISSN | 2168-8184 |
IngestDate | Tue Sep 17 21:28:00 EDT 2024 Fri Sep 27 17:22:48 EDT 2024 Thu Oct 10 22:31:46 EDT 2024 Fri Aug 23 04:59:22 EDT 2024 Wed Oct 23 09:54:06 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | lung cancer shared risk factors cardiovascular disease cancer treatment complications multidisciplinary care |
Language | English |
License | Copyright © 2024, Katic et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c300t-3924629106a0e5dd0c3034e097e84465be16cac13b2ecf055b2f8625e9e6db183 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11265258/ |
PMID | 39044884 |
PQID | 3086771025 |
PQPubID | 2045583 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11265258 proquest_miscellaneous_3084029981 proquest_journals_3086771025 crossref_primary_10_7759_cureus_62953 pubmed_primary_39044884 |
PublicationCentury | 2000 |
PublicationDate | 2024-06-23 |
PublicationDateYYYYMMDD | 2024-06-23 |
PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Palo Alto – name: Palo Alto (CA) |
PublicationTitle | Curēus (Palo Alto, CA) |
PublicationTitleAlternate | Cureus |
PublicationYear | 2024 |
Publisher | Cureus Inc Cureus |
Publisher_xml | – name: Cureus Inc – name: Cureus |
References | Ogawa H (ref56) 2021; 33 Maganti K (ref21) 2010; 85 Srinivasan NT (ref18) 2018; 7 Oser MG (ref23) 2015; 16 Eagle KA (ref12) 2002; 39 Kunimasa K (ref37) 2020; 2 Katic L (ref69) 2023; 13 Elhaj FA (ref13) 2016; 127 Kushnareva E (ref36) 2022; 13 Ahmed M (ref68) 2022; 119 Gujral DM (ref48) 2016; 102 Lee SY (ref78) 2002; 20 Carabello BA (ref22) 1997; 337 Blagus L (ref82) 2021; 39 Abravan A (ref45) 2022; 12 Osorio JC (ref77) 2017; 28 Upadhyay RK (ref7) 2015; 2015 Ball S (ref51) 2019; 74 Carver JR (ref5) 2007; 25 Zhao YW (ref28) 2022; 19 Cardinale D (ref54) 2016; 264 McGee K (ref65) 2021; 27 Li C (ref24) 2023; 136 Bade BC (ref25) 2020; 41 Zaborowska-Szmit M (ref38) 2020; 9 Zabłocka-Słowińska K (ref72) 2019; 14 Willemink MJ (ref44) 2015; 31 Filopei J (ref46) 2012; 20 Lazzerini PE (ref19) 2020; 142 Orthofer M (ref67) 2020; 181 de Boer RA (ref4) 2019; 21 Wit AL (ref14) 1983; 106 Jacobs PC (ref30) 2012; 198 Levenson B (ref2) 2020; 75 Tourmousoglou CE (ref32) 2014; 19 Voortman J (ref42) 2006; 6 Fradley MG (ref50) 2021; 144 Solomou E (ref83) 2019; 17 Doniger SJ (ref17) 2006; 53 Borlaug BA (ref11) 2010; 3 Sun M (ref29) 2022; 118 Glavic MM (ref81) 2021; 39 Kong M (ref59) 2021; 12 Cervantes-Madrid D (ref66) 2019; 9 van Hamersvelt RW (ref43) 2014; 24 Fineschi V (ref6) 2006 Chu G (ref53) 2019; 35 Joseph PG (ref16) 2021; 117 Carter BD (ref33) 2015; 372 Kanzaki R (ref31) 2017; 47 McCullough PA (ref9) 2002; 106 Buza V (ref49) 2017; 10 Nauta JF (ref10) 2017; 19 Yang Q (ref34) 2020; 114 von Lueder T (ref47) 2007; 22 Phelps CA (ref75) 2018; 106 Sahmoun AE (ref80) 2004; 24 Zipes DP (ref15) 2015; 12 Lin JJ (ref62) 2015; 191 Godwin JL (ref64) 2017; 5 Sung H (ref3) 2021; 71 Raisi-Estabragh Z (ref1) 2022; 9 Chen CF (ref41) 2018; 10 Zhuang X (ref26) 2019; 8 Raju S (ref27) 2018; 7 Albany C (ref76) 2011; 3 Stumpe KO (ref79) 2002; 20 Hardy D (ref35) 2010; 21 Vitols S (ref70) 1992; 52 Malakar AK (ref8) 2019; 234 Zipes DP (ref20) 1995; 26 Ratcliffe JG (ref73) 1978; 1 Hawryszko M (ref52) 2023; 15 Berghmans T (ref74) 2006; 17 Wang H (ref40) 2019; 15 Christensen AM (ref55) 2019; 21 Umeki S (ref71) 1993; 60 Zhang ZJ (ref60) 2014; 180 Ozerlat I (ref61) 2012; 8 Zhang M (ref58) 2014; 2 Yano T (ref39) 1997; 11 Shen Y (ref57) 2022; 11 Hung MS (ref63) 2019; 18 |
References_xml | – volume: 19 year: 2017 ident: ref10 article-title: What have we learned about heart failure with mid-range ejection fraction one year after its introduction? publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1058 contributor: fullname: Nauta JF – volume: 136 year: 2023 ident: ref24 article-title: Global burden and trends of lung cancer incidence and mortality publication-title: Chin Med J (Engl) doi: 10.1097/CM9.0000000000002529 contributor: fullname: Li C – volume: 17 year: 2006 ident: ref74 article-title: Thyroid transcription factor 1--a new prognostic factor in lung cancer: a meta-analysis publication-title: Ann Oncol doi: 10.1093/annonc/mdl287 contributor: fullname: Berghmans T – volume: 17 year: 2019 ident: ref83 article-title: Aortic wall stiffness as a side-effect of anti-cancer medication publication-title: Expert Rev Cardiovasc Ther doi: 10.1080/14779072.2019.1691528 contributor: fullname: Solomou E – volume: 5 year: 2017 ident: ref64 article-title: Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer publication-title: J Immunother Cancer doi: 10.1186/s40425-017-0245-2 contributor: fullname: Godwin JL – volume: 2015 year: 2015 ident: ref7 article-title: Emerging risk biomarkers in cardiovascular diseases and disorders publication-title: J Lipids doi: 10.1155/2015/971453 contributor: fullname: Upadhyay RK – volume: 12 year: 2015 ident: ref15 article-title: Antiarrhythmic therapy in 2014: contemporary approaches to treating arrhythmias publication-title: Nat Rev Cardiol doi: 10.1038/nrcardio.2014.211 contributor: fullname: Zipes DP – volume: 337 year: 1997 ident: ref22 article-title: Valvular heart disease publication-title: N Engl J Med doi: 10.1056/NEJM199707033370107 contributor: fullname: Carabello BA – volume: 35 year: 2019 ident: ref53 article-title: Atrial fibrillation and cancer - an unexplored field in cardiovascular oncology publication-title: Blood Rev doi: 10.1016/j.blre.2019.03.005 contributor: fullname: Chu G – volume: 52 year: 1992 ident: ref70 article-title: Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo publication-title: Cancer Res contributor: fullname: Vitols S – volume: 8 year: 2019 ident: ref26 article-title: Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF publication-title: Cancer Med doi: 10.1002/cam4.2183 contributor: fullname: Zhuang X – volume: 2 year: 2014 ident: ref58 article-title: Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer publication-title: Mol Clin Oncol doi: 10.3892/mco.2014.289 contributor: fullname: Zhang M – volume: 24 year: 2014 ident: ref43 article-title: Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability publication-title: Eur Radiol doi: 10.1007/s00330-014-3191-0 contributor: fullname: van Hamersvelt RW – volume: 33 year: 2021 ident: ref56 article-title: Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma publication-title: Interact Cardiovasc Thorac Surg doi: 10.1093/icvts/ivab140 contributor: fullname: Ogawa H – volume: 16 year: 2015 ident: ref23 article-title: Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin publication-title: Lancet Oncol doi: 10.1016/S1470-2045(14)71180-5 contributor: fullname: Oser MG – volume: 114 year: 2020 ident: ref34 article-title: Chemotherapy-related anatomical coronary-artery disease in lung cancer patients evaluated by coronary-angiography SYNTAX score publication-title: Arq Bras Cardiol doi: 10.36660/abc.20190201 contributor: fullname: Yang Q – volume: 9 year: 2019 ident: ref66 article-title: Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells publication-title: Sci Rep doi: 10.1038/s41598-019-55060-7 contributor: fullname: Cervantes-Madrid D – volume: 60 year: 1993 ident: ref71 article-title: Decreases in serum cholesterol levels in advanced lung cancer publication-title: Respiration doi: 10.1159/000196195 contributor: fullname: Umeki S – volume: 198 year: 2012 ident: ref30 article-title: Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.10.5577 contributor: fullname: Jacobs PC – volume: 39 year: 2002 ident: ref12 article-title: ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) publication-title: J Am Coll Cardiol doi: 10.1016/s0735-1097(01)01788-0 contributor: fullname: Eagle KA – volume: 119 year: 2022 ident: ref68 article-title: A hypothalamic pathway for Augmentor α-controlled body weight regulation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.2200476119 contributor: fullname: Ahmed M – volume: 75 year: 2020 ident: ref2 article-title: New ACC Global Heart Attack Treatment Initiative: improving STEMI care worldwide publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2020.03.001 contributor: fullname: Levenson B – volume: 118 year: 2022 ident: ref29 article-title: Association between the severity of coronary artery disease and lung cancer: a pilot cross-sectional study publication-title: Arq Bras Cardiol doi: 10.36660/abc.20200478 contributor: fullname: Sun M – volume: 15 year: 2023 ident: ref52 article-title: Cardiac arrhythmias in patients treated for lung cancer: a review publication-title: Cancers (Basel) doi: 10.3390/cancers15245723 contributor: fullname: Hawryszko M – volume: 21 year: 2019 ident: ref55 article-title: Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study publication-title: Europace doi: 10.1093/europace/euy268 contributor: fullname: Christensen AM – volume: 3 year: 2010 ident: ref11 article-title: Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.109.930701 contributor: fullname: Borlaug BA – volume: 2 year: 2020 ident: ref37 article-title: Cardiac adverse events in EGFR-mutated non-small cell lung cancer treated with osimertinib publication-title: JACC CardioOncol doi: 10.1016/j.jaccao.2020.02.003 contributor: fullname: Kunimasa K – volume: 234 year: 2019 ident: ref8 article-title: A review on coronary artery disease, its risk factors, and therapeutics publication-title: J Cell Physiol doi: 10.1002/jcp.28350 contributor: fullname: Malakar AK – volume: 127 year: 2016 ident: ref13 article-title: Arrhythmia recognition and classification using combined linear and nonlinear features of ECG signals publication-title: Comput Methods Programs Biomed doi: 10.1016/j.cmpb.2015.12.024 contributor: fullname: Elhaj FA – volume: 28 year: 2017 ident: ref77 article-title: Antibody-mediated thyroid dysfunction during T-cell checkpoint blockade in patients with non-small-cell lung cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdw640 contributor: fullname: Osorio JC – volume: 7 year: 2018 ident: ref18 article-title: Sudden cardiac death and arrhythmias publication-title: Arrhythm Electrophysiol Rev doi: 10.15420/aer.2018:15:2 contributor: fullname: Srinivasan NT – volume: 20 year: 2002 ident: ref79 article-title: Hypertension and the risk of cancer: is there new evidence? publication-title: J Hypertens doi: 10.1097/00004872-200204000-00003 contributor: fullname: Stumpe KO – volume: 191 year: 2015 ident: ref62 article-title: Survival of patients with stage IV lung cancer with diabetes treated with metformin publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201407-1395OC contributor: fullname: Lin JJ – year: 2006 ident: ref6 article-title: Pathology of the Heart and Sudden Death in Forensic Medicine doi: 10.1201/9781420006438 contributor: fullname: Fineschi V – volume: 372 year: 2015 ident: ref33 article-title: Smoking and mortality--beyond established causes publication-title: N Engl J Med doi: 10.1056/NEJMsa1407211 contributor: fullname: Carter BD – volume: 180 year: 2014 ident: ref60 article-title: Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis publication-title: Am J Epidemiol doi: 10.1093/aje/kwu124 contributor: fullname: Zhang ZJ – volume: 85 year: 2010 ident: ref21 article-title: Valvular heart disease: diagnosis and management publication-title: Mayo Clin Proc doi: 10.4065/mcp.2009.0706 contributor: fullname: Maganti K – volume: 53 year: 2006 ident: ref17 article-title: Pediatric dysrhythmias publication-title: Pediatr Clin North Am doi: 10.1016/j.pcl.2005.10.004 contributor: fullname: Doniger SJ – volume: 21 year: 2019 ident: ref4 article-title: Cancer and heart disease: associations and relations publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1539 contributor: fullname: de Boer RA – volume: 142 year: 2020 ident: ref19 article-title: COVID-19, arrhythmic risk, and inflammation: mind the gap! publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.047293 contributor: fullname: Lazzerini PE – volume: 11 year: 1997 ident: ref39 article-title: The current status of postoperative complications and risk factors after a pulmonary resection for primary lung cancer. A multivariate analysis publication-title: Eur J Cardiothorac Surg doi: 10.1016/s1010-7940(96)01097-4 contributor: fullname: Yano T – volume: 22 year: 2007 ident: ref47 article-title: Rheumatic mitral valve stenosis mimicking advanced lung cancer publication-title: Heart Vessels doi: 10.1007/s00380-007-0979-8 contributor: fullname: von Lueder T – volume: 21 year: 2010 ident: ref35 article-title: Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer publication-title: Ann Oncol doi: 10.1093/annonc/mdq042 contributor: fullname: Hardy D – volume: 12 year: 2021 ident: ref59 article-title: Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non-small cell lung cancer patients treated with radiotherapy publication-title: Thorac Cancer doi: 10.1111/1759-7714.14174 contributor: fullname: Kong M – volume: 71 year: 2021 ident: ref3 article-title: Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J Clin doi: 10.3322/caac.21660 contributor: fullname: Sung H – volume: 106 year: 1983 ident: ref14 article-title: Pathophysiologic mechanisms of cardiac arrhythmias publication-title: Am Heart J doi: 10.1016/0002-8703(83)90003-0 contributor: fullname: Wit AL – volume: 9 year: 2020 ident: ref38 article-title: Cardiovascular complications of systemic therapy in non-small-cell lung cancer publication-title: J Clin Med doi: 10.3390/jcm9051268 contributor: fullname: Zaborowska-Szmit M – volume: 3 year: 2011 ident: ref76 article-title: Lung cancer, thyroid cancer or both: An unusual case presentation publication-title: J Thorac Dis doi: 10.3978/j.issn.2072-1439.2011.02.03 contributor: fullname: Albany C – volume: 25 year: 2007 ident: ref5 article-title: American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects publication-title: J Clin Oncol doi: 10.1200/JCO.2007.10.9777 contributor: fullname: Carver JR – volume: 102 year: 2016 ident: ref48 article-title: Radiation-induced valvular heart disease publication-title: Heart doi: 10.1136/heartjnl-2015-308765 contributor: fullname: Gujral DM – volume: 106 year: 2002 ident: ref9 article-title: B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study publication-title: Circulation doi: 10.1161/01.cir.0000025242.79963.4c contributor: fullname: McCullough PA – volume: 27 year: 2021 ident: ref65 article-title: A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy publication-title: J Oncol Pharm Pract doi: 10.1177/10781552211004698 contributor: fullname: McGee K – volume: 10 year: 2017 ident: ref49 article-title: Cancer treatment-induced arrhythmias: focus on chemotherapy and targeted therapies publication-title: Circ Arrhythm Electrophysiol doi: 10.1161/CIRCEP.117.005443 contributor: fullname: Buza V – volume: 74 year: 2019 ident: ref51 article-title: Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2019.07.079 contributor: fullname: Ball S – volume: 19 year: 2022 ident: ref28 article-title: Inflammation-based different association between anatomical severity of coronary artery disease and lung cancer publication-title: J Geriatr Cardiol doi: 10.11909/j.issn.1671-5411.2022.08.003 contributor: fullname: Zhao YW – volume: 14 year: 2019 ident: ref72 article-title: Oxidative stress in lung cancer patients is associated with altered serum markers of lipid metabolism publication-title: PLoS One doi: 10.1371/journal.pone.0215246 contributor: fullname: Zabłocka-Słowińska K – volume: 1 year: 1978 ident: ref73 article-title: Thyroid function in lung cancer publication-title: Br Med J doi: 10.1136/bmj.1.6107.210 contributor: fullname: Ratcliffe JG – volume: 41 year: 2020 ident: ref25 article-title: Lung cancer 2020: epidemiology, etiology, and prevention publication-title: Clin Chest Med doi: 10.1016/j.ccm.2019.10.001 contributor: fullname: Bade BC – volume: 9 year: 2022 ident: ref1 article-title: Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019 publication-title: Eur Heart J Qual Care Clin Outcomes doi: 10.1093/ehjqcco/qcac016 contributor: fullname: Raisi-Estabragh Z – volume: 20 year: 2002 ident: ref78 article-title: Does hypertension increase mortality risk from lung cancer? A prospective cohort study on smoking, hypertension and lung cancer risk among Korean men publication-title: J Hypertens doi: 10.1097/00004872-200204000-00017 contributor: fullname: Lee SY – volume: 13 year: 2022 ident: ref36 article-title: Case report: multiple causes of cardiac death after the first infusion of atezolizumab: histopathological and immunohistochemical findings publication-title: Front Immunol doi: 10.3389/fimmu.2022.871542 contributor: fullname: Kushnareva E – volume: 6 year: 2006 ident: ref42 article-title: Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report publication-title: BMC Cancer doi: 10.1186/1471-2407-6-129 contributor: fullname: Voortman J – volume: 20 year: 2012 ident: ref46 article-title: Radiation-induced heart disease publication-title: Cardiol Rev doi: 10.1097/CRD.0b013e3182431c23 contributor: fullname: Filopei J – volume: 19 year: 2014 ident: ref32 article-title: Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy? publication-title: Interact Cardiovasc Thorac Surg doi: 10.1093/icvts/ivu218 contributor: fullname: Tourmousoglou CE – volume: 18 year: 2019 ident: ref63 article-title: Metformin prolongs survival in type 2 diabetes lung cancer patients with EGFR-TKIs publication-title: Integr Cancer Ther doi: 10.1177/1534735419869491 contributor: fullname: Hung MS – volume: 181 year: 2020 ident: ref67 article-title: Identification of ALK in thinness publication-title: Cell doi: 10.1016/j.cell.2020.04.034 contributor: fullname: Orthofer M – volume: 106 year: 2018 ident: ref75 article-title: Roles of thyroid transcription factor 1 in lung cancer biology publication-title: Vitam Horm doi: 10.1016/bs.vh.2017.05.007 contributor: fullname: Phelps CA – volume: 264 year: 2016 ident: ref54 article-title: Prevention of atrial fibrillation in high-risk patients undergoing lung cancer surgery: the PRESAGE Trial publication-title: Ann Surg doi: 10.1097/SLA.0000000000001626 contributor: fullname: Cardinale D – volume: 144 year: 2021 ident: ref50 article-title: Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000000986 contributor: fullname: Fradley MG – volume: 31 year: 2015 ident: ref44 article-title: Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population publication-title: Int J Cardiovasc Imaging doi: 10.1007/s10554-015-0664-4 contributor: fullname: Willemink MJ – volume: 11 year: 2022 ident: ref57 article-title: A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumab publication-title: Transl Lung Cancer Res doi: 10.21037/tlcr-22-493 contributor: fullname: Shen Y – volume: 7 year: 2018 ident: ref27 article-title: Review of checkpoint immunotherapy for the management of non-small cell lung cancer publication-title: Immunotargets Ther doi: 10.2147/ITT.S125070 contributor: fullname: Raju S – volume: 15 year: 2019 ident: ref40 article-title: Radiation-induced heart disease: a review of classification, mechanism and prevention publication-title: Int J Biol Sci doi: 10.7150/ijbs.35460 contributor: fullname: Wang H – volume: 39 year: 2021 ident: ref82 article-title: Estimated pulse wave velocity (EPWV) and mortality in subjects with healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study publication-title: J Hypertens doi: 10.1097/01.hjh.0000746336.69196.25 contributor: fullname: Blagus L – volume: 12 year: 2022 ident: ref45 article-title: Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy publication-title: Front Oncol doi: 10.3389/fonc.2022.934369 contributor: fullname: Abravan A – volume: 47 year: 2017 ident: ref31 article-title: Outcomes of lung cancer surgery in patients with coronary artery disease: a decade of experience at a single institution publication-title: Surg Today doi: 10.1007/s00595-016-1355-z contributor: fullname: Kanzaki R – volume: 117 year: 2021 ident: ref16 article-title: Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals publication-title: Cardiovasc Res doi: 10.1093/cvr/cvaa241 contributor: fullname: Joseph PG – volume: 8 year: 2012 ident: ref61 article-title: Cancer: diabetes therapy and lung cancer publication-title: Nat Rev Endocrinol doi: 10.1038/nrendo.2012.99 contributor: fullname: Ozerlat I – volume: 24 year: 2004 ident: ref80 article-title: Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study publication-title: Anticancer Res contributor: fullname: Sahmoun AE – volume: 26 year: 1995 ident: ref20 article-title: Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology publication-title: J Am Coll Cardiol doi: 10.1016/0735-1097(95)80037-h contributor: fullname: Zipes DP – volume: 39 year: 2021 ident: ref81 article-title: Characteristics of healthy vascular ageing (HVA) and early vascular ageing (EVA) in general population. EH-UH Study (Croatian Scientific Foundation) publication-title: J Hypertens doi: 10.1097/01.hjh.0000745076.39504.af contributor: fullname: Glavic MM – volume: 10 year: 2018 ident: ref41 article-title: Effective cardiac radiotherapy relieved life-threatening heart failure caused by advanced small cell lung cancer with cardiac metastasis: a case report publication-title: J Thorac Dis doi: 10.21037/jtd.2018.03.104 contributor: fullname: Chen CF – volume: 13 year: 2023 ident: ref69 article-title: Multifaceted roles of ALK family receptors and augmentor ligands in health and disease: a comprehensive review publication-title: Biomolecules doi: 10.3390/biom13101490 contributor: fullname: Katic L |
SSID | ssj0001072070 |
Score | 2.3136287 |
SecondaryResourceType | review_article |
Snippet | Cardiovascular disease (CVD) and lung cancer are among the leading causes of mortality worldwide, with a significant interplay that complicates patient... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | e62953 |
SubjectTerms | Angina pectoris Beta blockers Cancer therapies Cardiac arrhythmia Cardiology Cardiovascular disease Cardioversion Chronic illnesses Congenital diseases Coronary vessels Coronaviruses COVID-19 Diabetes Heart failure Hyperlipidemia Hypertension Ischemia Lung cancer Medical imaging Mortality Oncology Peptides Risk factors Side effects Thyroid diseases Vein & artery diseases |
SummonAdditionalLinks | – databaseName: Coronavirus Research Database dbid: COVID link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSwMxEB60gnjx_ahWWUGPW9M89gGCaLWoWL1Y6W3JZrMoyra23YP-eiebbbUVPHjdCSQ7M5lH5ssE4IhS5XtSpm5KQuJyKrkrU6lcqTj6Uyo9UlwUbt971x1-2xXd8sBtWMIqxzaxMNRJT5kz8hNGTOc1dIfirP_umlejTHW1fEJjHhZYgJlOBRaaD083l9-nLMSnqNQW8e77IjxR-UDnw7pHQ8GmfdGvAHMWJ_nD8bRWIBov2eJNXuv5KK6rz5lujv__p1VYLmNS59wq0RrM6WwdFttl1X0DTlGXHItOfJMfzoWFdjnNKSirc2lLPY7MEucOTQjSUaEGm9BpXT02r93y1QVXMUJGLgZMHLmDqaIkWiQJwc-MaxL6OjDd1WLd8JRUDRZTrVIiRExTTIuEDrWXxGghtqCS9TK9A07AmRezQMokUFzqMMb4LhVJIyUpY5I1qnA85n_Ut801IkxKjJwiK6eokFMVamP-ReUWG0bfzKvC4YSMm8NUPGSme3kxBvNjzChxqm0ry8lELCSYmga8CsGUlCcDTOPtaUr28lw04DbXrgQVwe7f69qDJYohkAGWUVaDymiQ630MYUbxQamnXxeh9bY priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFD7MCeKLeLc6pYI-dma59AKC6HQMcT452FtJ0xSF0Wm3gvv3nvQyrPrka5OQ8J0T8n3NyTkAF5Qqz5UycRISEIdTyR2ZSOVIxfE8pdIlxUPh0bM7HPPHiZi0oK42WgE4_1PamXpS42za_fxY3uCGR_7a9TwRXKk80_m869JAsDVYp5xx4-ujiugXf1uIR9G5y8j3X4OaZ9IvovkzXvLbATTYhq2KOdq3pal3oKXTXdgYVXfje3CNFrfLGMKpXNp3ZQCW3W8EnNr35YWMLdPYfsKNju1o9mwfxoOHl_7QqWojOIoRsnCQ1nBcOwo6SbSIY4KfGdck8LRvcqBFuucqqXosololRIiIJihehA60G0e4jw-gnc5SfQS2z5kbMV_K2Fdc6iBCFpaIuJeQhDHJehZc1uiE72UKjBClg0ExLFEMCxQt6NTQhbUdQ0ZMwjxkMcKC81UzurC5l5CpnuVFH1SxqPtwqsMS6dVELCAoIH1ugd-wwaqDSY_dbEnfXos02eZxlKDCP_7_0BPYpEhiTGgYZR1oL7JcnyIJWURnhX99ASGf4Hk priority: 102 providerName: Scholars Portal |
Title | The Interplay Between Cardiovascular Disease and Lung Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39044884 https://www.proquest.com/docview/3086771025 https://www.proquest.com/docview/3084029981/abstract/ https://pubmed.ncbi.nlm.nih.gov/PMC11265258 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT8IwGP2CmBhfjHdRJDPRx0HpZZfEF7kFjSAxYnhbuq6LJDAIsAf_vd82RkDffFrSdmnz9TQ9Zz39BnBPqbItKUMzJC4xOZXclKFUplQc91MqLZJeFO71re6Qv4zEqABWfhcmNe0rf1yNJtNqNP5KvZXzqarlPrHaoNdMrr0IKpzaHuzZjG1p9PTLCrEpAjlzudu2cGsqXuh4WbWoK9ju_vOHVP72Rm5tNp1jOFqzROMpG80JFHR0Cge99Tn4GTzi7BqZX3Aiv41GZrYymjvmUqOVHb4YMgqMV1zUWI9TvDiHYaf90eya6_8gmIoRsjKRwnAcO4o3SbQIAoLFjGvi2tpJ8p35um4pqerMp1qFRAifhihUhHa1Ffi4Zi-gGM0ifQWGw5nlM0fKwFFcatdHxhWKoB6SkDHJ6iV4yKPjzbN0Fx7KhCSKXhZFL41iCcp56Lw16JceI0lyPGQsogR3m2qEa3IGISM9i9M2qFhR42FXl1mkNx0xl6BYdHgJnJ052DRIUmHv1iBC0pTYOSKu___qDRxSJCyJDYyyMhRXi1jfIuFY-RVE2ciuwH6j3R-847P59vncwtIedyop9n4AqK_eAg |
link.rule.ids | 230,315,733,786,790,891,2236,12083,21416,24346,27955,27956,31752,31753,33777,33778,38549,43343,43838,43928,53825,53827,74100,74657,74767 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZgSMCF92M8iwTHblkefUhICAZowAYXQNyqNE0FAnWwrQf49ThNNxhIHLjWkZLajh_xFwdgn1Lle1KmbkpC4nIquStTqVypOPpTKj1SXBTuXHutO375IB7KA7d-Casc2sTCUCddZc7I64yYzmvoDsXR65trXo0y1dXyCY1JmELHSoMKTDVv7i9Ov05ZiE9RqS3i3fdFWFd5T-f9mkdDwcZ90a8A8ydO8pvjOZ-HaLhkizd5ruWDuKY-fnRz_P8_LcBcGZM6x1aJFmFCZ0sw3Smr7stwiLrkWHTii3x3Tiy0y2mOQVmdU1vqcWSWOG00IUhHheqtwN352W2z5ZavLriKETJwkY8cuYOpoiRaJAnBz4xrEvo6MN3VYt3wlFQNFlOtUiJETFNMi4QOtZfEaCFWoZJ1M70OTsCZF7NAyiRQXOowxvguFUkjJSljkjWqcDDkf_Rqm2tEmJQYOUVWTlEhpypsDfkXlVusH30xrwp7IzJuDlPxkJnu5sUYzI8xo8Sp1qwsRxOxkGBqGvAqBGNSHg0wjbfHKdnTY9GA21y7ElQEG3-vaxdmWreddtS-uL7ahFmK4ZABmVG2BZVBL9fbGM4M4p1SZz8Bs9D4nQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LTxsxEB4VIiEuQB9AeLRbqRw3cfzYh4SEICHiXQ6l4rbyem21Am0gyR7g1zNeO6FJJU5c15bs9Yxn5vN8HgP8oFTFkZQmNCQlIaeSh9JIFUrF0Z9SGZH6ovDlVXRyw89uxa3nP408rXJiE2tDXQyUPSNvM2Irr6E7FG3jaRHXvf7Bw2NoX5CymVb_nMYCNDBEjhCINbo_f5_2Xk9cSExRwR37PY5F2lbVUFejVkRTwWb90n_B5jxn8h8n1F-Fu8n0HffkrlWN85Z6nqvs-D7_twYrPlYNDp1yfYQPuvwES5c-G_8Z9lHHAsdavJdPwZGjfAXdGYpr0HMpoECWRXCBpgXbUdGGX-Cmf_yrexL61xhCxQgZhxhIcVwphJCSaFEUBD8zrkka68RWXct1J1JSdVhOtTJEiJwahEtCpzoqcrQc67BYDkq9CUHCWZSzRMoiUVzqNMe4z4iiY4hhTLJOE_YmssgeXNGNDMGKlVnmZJbVMmvCzmQtM7_1RtnrQjbh-7QZN43NhMhSD6q6D-JmRJo41IaT63QglhKErAlvQjIj8WkHW5B7tqX8-6cuzG2vYwkqkq235_UNllC02cXp1fk2LFOMkiz3jLIdWBwPK72LUc44_-rV9wXKRgFv |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Interplay+Between+Cardiovascular+Disease+and+Lung+Cancer&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Katic%2C+Luka&rft.au=Choi%2C+James&rft.au=Diaz+Saravia%2C+Sara&rft.au=Silverman%2C+Alexander&rft.date=2024-06-23&rft.pub=Cureus&rft.eissn=2168-8184&rft.volume=16&rft.issue=6&rft_id=info:doi/10.7759%2Fcureus.62953&rft.externalDBID=PMC11265258 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon |